RU2018121254A - Высокоэффективное построение библиотек днк - Google Patents
Высокоэффективное построение библиотек днк Download PDFInfo
- Publication number
- RU2018121254A RU2018121254A RU2018121254A RU2018121254A RU2018121254A RU 2018121254 A RU2018121254 A RU 2018121254A RU 2018121254 A RU2018121254 A RU 2018121254A RU 2018121254 A RU2018121254 A RU 2018121254A RU 2018121254 A RU2018121254 A RU 2018121254A
- Authority
- RU
- Russia
- Prior art keywords
- dna
- oligonucleotide
- ligated
- adapter
- genetic
- Prior art date
Links
- 238000010276 construction Methods 0.000 title 1
- 108020004414 DNA Proteins 0.000 claims 100
- 108091034117 Oligonucleotide Proteins 0.000 claims 61
- 238000000034 method Methods 0.000 claims 60
- 102000053602 DNA Human genes 0.000 claims 26
- 230000002068 genetic effect Effects 0.000 claims 15
- 238000012252 genetic analysis Methods 0.000 claims 11
- 108090000790 Enzymes Proteins 0.000 claims 10
- 102000004190 Enzymes Human genes 0.000 claims 10
- 208000026350 Inborn Genetic disease Diseases 0.000 claims 10
- 208000016361 genetic disease Diseases 0.000 claims 10
- 239000000523 sample Substances 0.000 claims 10
- 239000012472 biological sample Substances 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 8
- 239000012530 fluid Substances 0.000 claims 7
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 231100000722 genetic damage Toxicity 0.000 claims 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 5
- 238000012545 processing Methods 0.000 claims 5
- 108020004635 Complementary DNA Proteins 0.000 claims 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 238000010804 cDNA synthesis Methods 0.000 claims 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 4
- 230000000295 complement effect Effects 0.000 claims 4
- 239000002299 complementary DNA Substances 0.000 claims 4
- 230000004927 fusion Effects 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 210000003296 saliva Anatomy 0.000 claims 4
- 210000004243 sweat Anatomy 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 4
- 238000001712 DNA sequencing Methods 0.000 claims 3
- 210000004381 amniotic fluid Anatomy 0.000 claims 3
- 230000003321 amplification Effects 0.000 claims 3
- 239000000090 biomarker Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 230000008859 change Effects 0.000 claims 3
- 238000012217 deletion Methods 0.000 claims 3
- 230000037430 deletion Effects 0.000 claims 3
- 239000000539 dimer Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 238000003780 insertion Methods 0.000 claims 3
- 230000037431 insertion Effects 0.000 claims 3
- 230000001926 lymphatic effect Effects 0.000 claims 3
- 210000003097 mucus Anatomy 0.000 claims 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims 3
- 230000000771 oncological effect Effects 0.000 claims 3
- 210000002381 plasma Anatomy 0.000 claims 3
- 238000003753 real-time PCR Methods 0.000 claims 3
- 230000008707 rearrangement Effects 0.000 claims 3
- 210000000582 semen Anatomy 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 230000007704 transition Effects 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 238000012408 PCR amplification Methods 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 2
- 238000001574 biopsy Methods 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 239000012188 paraffin wax Substances 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 210000004909 pre-ejaculatory fluid Anatomy 0.000 claims 2
- 230000008439 repair process Effects 0.000 claims 2
- 108091023043 Alu Element Proteins 0.000 claims 1
- 206010003445 Ascites Diseases 0.000 claims 1
- 231100000277 DNA damage Toxicity 0.000 claims 1
- 230000005778 DNA damage Effects 0.000 claims 1
- 108091093078 Pyrimidine dimer Proteins 0.000 claims 1
- ASJWEHCPLGMOJE-LJMGSBPFSA-N ac1l3rvh Chemical compound N1C(=O)NC(=O)[C@@]2(C)[C@@]3(C)C(=O)NC(=O)N[C@H]3[C@H]21 ASJWEHCPLGMOJE-LJMGSBPFSA-N 0.000 claims 1
- 238000007622 bioinformatic analysis Methods 0.000 claims 1
- 238000003766 bioinformatics method Methods 0.000 claims 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 210000004209 hair Anatomy 0.000 claims 1
- 210000003780 hair follicle Anatomy 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 210000002751 lymph Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000002200 mouth mucosa Anatomy 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 229940035893 uracil Drugs 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/191—Modifications characterised by incorporating an adaptor
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562254110P | 2015-11-11 | 2015-11-11 | |
| US62/254,110 | 2015-11-11 | ||
| PCT/US2016/061395 WO2017083562A1 (en) | 2015-11-11 | 2016-11-10 | High efficiency construction of dna libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018121254A true RU2018121254A (ru) | 2019-12-16 |
Family
ID=58695623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018121254A RU2018121254A (ru) | 2015-11-11 | 2016-11-10 | Высокоэффективное построение библиотек днк |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11339391B2 (enExample) |
| EP (2) | EP3889257A1 (enExample) |
| JP (4) | JP6913089B2 (enExample) |
| KR (1) | KR102788327B1 (enExample) |
| CN (2) | CN108431233B (enExample) |
| AU (1) | AU2016353133B2 (enExample) |
| CA (1) | CA3004435A1 (enExample) |
| DK (1) | DK3374525T3 (enExample) |
| ES (1) | ES2856598T3 (enExample) |
| IL (2) | IL285202B2 (enExample) |
| MX (2) | MX2018005858A (enExample) |
| RU (1) | RU2018121254A (enExample) |
| WO (1) | WO2017083562A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3561072A1 (en) | 2012-12-10 | 2019-10-30 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| EP3889257A1 (en) | 2015-11-11 | 2021-10-06 | Resolution Bioscience, Inc. | High efficiency construction of dna libraries |
| AU2017315769B2 (en) | 2016-08-25 | 2024-02-01 | Resolution Bioscience, Inc. | Methods for the detection of genomic copy changes in DNA samples |
| US20210404007A1 (en) * | 2017-06-30 | 2021-12-30 | The Regents Of The University Of California | Methods and systems for evaluating dna methylation in cell-free dna |
| AU2018328324B2 (en) | 2017-09-11 | 2024-12-12 | Ludwig Institute For Cancer Research Ltd | Selective labeling of 5-methylcytosine in circulating cell-free DNA |
| TWI833715B (zh) | 2017-10-27 | 2024-03-01 | 美商奇諾診療公司 | 用於超低體積液體生物檢體之裝置、系統及方法 |
| JP2021514663A (ja) * | 2018-03-08 | 2021-06-17 | セント・ジョーンズ・ユニバーシティＳｔ． Ｊｏｈｎｓ Ｕｎｉｖｅｒｓｉｔｙ | 循環性血清無細胞ｄｎａバイオマーカー及び方法 |
| CA3095030A1 (en) | 2018-03-30 | 2019-10-03 | Juno Diagnostics, Inc. | Deep learning-based methods, devices, and systems for prenatal testing |
| WO2019195268A2 (en) | 2018-04-02 | 2019-10-10 | Grail, Inc. | Methylation markers and targeted methylation probe panels |
| CA3107052A1 (en) | 2018-07-24 | 2020-01-30 | Ripple Biosolutions Llc | Methods and composition for targeted genomic analysis |
| AU2019351130B2 (en) | 2018-09-27 | 2025-10-23 | GRAIL, Inc | Methylation markers and targeted methylation probe panel |
| US11781169B2 (en) | 2018-10-05 | 2023-10-10 | Microsoft Technology Licensing, Llc | Enzymatic DNA repair |
| CN111074353B (zh) * | 2018-10-18 | 2023-10-13 | 深圳华大智造科技股份有限公司 | 全基因组甲基化文库单链建库方法和得到的全基因组甲基化文库 |
| US11926821B2 (en) * | 2018-10-22 | 2024-03-12 | The Chinese University Of Hong Kong | Cell-free DNA quality |
| CN109576799B (zh) * | 2018-11-30 | 2022-04-26 | 深圳安吉康尔医学检验实验室 | Fh测序文库的构建方法和引物组及试剂盒 |
| KR20220004645A (ko) * | 2019-03-27 | 2022-01-11 | 주노 다이어그노스틱스, 인크. | 최적화된 초저 부피 액체 생검 방법, 시스템 및 장치 |
| GB202013141D0 (en) * | 2020-08-21 | 2020-10-07 | Univ College Cardiff Consultants Ltd | A screening method for the detection of DNA damage |
| KR20230065295A (ko) * | 2020-09-08 | 2023-05-11 | 레졸루션 바이오사이언스, 인크. | 유전자 라이브러리 및 유전자 분석의 고효율성 구축을 위한 어댑터 및 방법 |
| CN114317528A (zh) * | 2020-09-30 | 2022-04-12 | 北京吉因加科技有限公司 | 特异分子标签umi组、混合特异分子标签接头及应用 |
| CN114438184B (zh) * | 2022-04-08 | 2022-07-12 | 昌平国家实验室 | 游离dna甲基化测序文库构建方法及应用 |
Family Cites Families (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591582A (en) | 1985-07-23 | 1997-01-07 | The Board Of Rijks Universiteit Leiden | Methods for detecting activated RAS oncogenes |
| US5888731A (en) | 1995-08-30 | 1999-03-30 | Visible Genetics Inc. | Method for identification of mutations using ligation of multiple oligonucleotide probes |
| JP2002511767A (ja) | 1997-08-28 | 2002-04-16 | ピーイー コーポレイション（エヌワイ） | 化学切断による、核酸における変異の改良された検出 |
| US6480791B1 (en) | 1998-10-28 | 2002-11-12 | Michael P. Strathmann | Parallel methods for genomic analysis |
| US6812341B1 (en) | 2001-05-11 | 2004-11-02 | Ambion, Inc. | High efficiency mRNA isolation methods and compositions |
| AU2002365028A1 (en) | 2001-07-17 | 2003-06-30 | Stratagene | Methods for detection of a target nucleic acid using multi-subunit probes |
| AU2002322518A1 (en) | 2001-08-31 | 2003-03-18 | Rosetta Inpharmactis Llc | Methods for preparing nucleic acid samples |
| US7361821B2 (en) | 2002-09-20 | 2008-04-22 | Intel Corporation | Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (SPM) reading |
| AU2003284420A1 (en) * | 2002-12-11 | 2004-06-30 | Keio University | Method of constructing assigned molecule and library comprising the same and method of using the same |
| TW200506052A (en) | 2003-05-07 | 2005-02-16 | Takara Bio Inc | Method of analyzing DNA region |
| US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
| US20090264305A1 (en) | 2005-07-07 | 2009-10-22 | Athlomics Pty Ltd. | Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia |
| GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
| US7939645B2 (en) | 2006-01-06 | 2011-05-10 | Agilent Technologies, Inc | Reaction buffer composition for nucleic acid replication with packed DNA polymerases |
| US7537897B2 (en) | 2006-01-23 | 2009-05-26 | Population Genetics Technologies, Ltd. | Molecular counting |
| US8383338B2 (en) | 2006-04-24 | 2013-02-26 | Roche Nimblegen, Inc. | Methods and systems for uniform enrichment of genomic regions |
| US7754429B2 (en) | 2006-10-06 | 2010-07-13 | Illumina Cambridge Limited | Method for pair-wise sequencing a plurity of target polynucleotides |
| US8568979B2 (en) | 2006-10-10 | 2013-10-29 | Illumina, Inc. | Compositions and methods for representational selection of nucleic acids from complex mixtures using hybridization |
| US12180549B2 (en) | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| US8067164B2 (en) | 2007-08-12 | 2011-11-29 | Integrated Dna Technologies, Inc. | Microarray system with improved sequence specificity |
| US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
| CA2707901C (en) * | 2007-12-05 | 2015-09-15 | Complete Genomics, Inc. | Efficient base determination in sequencing reactions |
| WO2009091798A1 (en) | 2008-01-16 | 2009-07-23 | Helicos Biosciences Corporation | Quantitative genetic analysis |
| US8202691B2 (en) | 2008-01-25 | 2012-06-19 | Illumina, Inc. | Uniform fragmentation of DNA using binding proteins |
| EP2334802A4 (en) * | 2008-09-09 | 2012-01-25 | Life Technologies Corp | METHODS OF GENERATING SPECIFIC LIBRARIES OF GENES |
| US8383345B2 (en) | 2008-09-12 | 2013-02-26 | University Of Washington | Sequence tag directed subassembly of short sequencing reads into long sequencing reads |
| US8728764B2 (en) | 2008-10-02 | 2014-05-20 | Illumina Cambridge Limited | Nucleic acid sample enrichment for sequencing applications |
| WO2010068856A1 (en) | 2008-12-11 | 2010-06-17 | Trustees Of Boston University | Isolation of rna |
| EP2414547B1 (en) | 2009-04-02 | 2014-03-12 | Fluidigm Corporation | Multi-primer amplification method for barcoding of target nucleic acids |
| US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
| US20110003301A1 (en) | 2009-05-08 | 2011-01-06 | Life Technologies Corporation | Methods for detecting genetic variations in dna samples |
| EP2470669B1 (en) | 2009-08-25 | 2014-06-18 | Illumina, Inc. | Methods for selecting and amplifying polynucleotides |
| US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
| US9315857B2 (en) | 2009-12-15 | 2016-04-19 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse label-tags |
| US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
| US10378064B1 (en) | 2010-04-16 | 2019-08-13 | Chronix Biomedical | Analyzing circulating nucleic acids to identify a biomarker representative of cancer presented by a patient population |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US8828688B2 (en) | 2010-05-27 | 2014-09-09 | Affymetrix, Inc. | Multiplex amplification methods |
| CN103119439A (zh) | 2010-06-08 | 2013-05-22 | 纽亘技术公司 | 用于多重测序的方法和组合物 |
| EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| KR20130113447A (ko) | 2010-09-24 | 2013-10-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 고정된 프라이머들을 이용하여 표적 dna의 직접적인 캡쳐, 증폭 및 서열화 |
| SG190344A1 (en) | 2010-11-30 | 2013-06-28 | Univ Hong Kong Chinese | Detection of genetic or molecular aberrations associated with cancer |
| KR20190002733A (ko) | 2010-12-30 | 2019-01-08 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
| BR112013020220B1 (pt) | 2011-02-09 | 2020-03-17 | Natera, Inc. | Método para determinar o estado de ploidia de um cromossomo em um feto em gestação |
| US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| LT3567124T (lt) | 2011-04-12 | 2022-04-11 | Verinata Health, Inc. | Genominių frakcijų paskirstymas, naudojant polimorfizmo skaičiavimo rezultatus |
| DK3246416T3 (da) | 2011-04-15 | 2024-09-02 | Univ Johns Hopkins | Sikkert sekventeringssystem |
| WO2013056178A2 (en) | 2011-10-14 | 2013-04-18 | Foundation Medicine, Inc. | Novel estrogen receptor mutations and uses thereof |
| CN103103624B (zh) * | 2011-11-15 | 2014-12-31 | 深圳华大基因科技服务有限公司 | 高通量测序文库的构建方法及其应用 |
| US10227587B2 (en) | 2012-01-10 | 2019-03-12 | Berry Genomics Co., Ltd. | Method for constructing a plasma DNA sequencing library |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| EP4234713A3 (en) | 2012-03-20 | 2024-02-14 | University Of Washington Through Its Center For Commercialization | Methods of lowering the error rate of massively parallel dna sequencing using duplex consensus sequencing |
| US20130288915A1 (en) | 2012-04-27 | 2013-10-31 | Htg Molecular Diagnostics, Inc. | Compositions and methods for alk molecular testing |
| WO2013181170A1 (en) | 2012-05-31 | 2013-12-05 | Board Of Regents, The University Of Texas System | Method for accurate sequencing of dna |
| SG10201610861XA (en) | 2012-07-03 | 2017-02-27 | Integrated Dna Tech Inc | Tm-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection |
| SI2880447T1 (sl) | 2012-07-31 | 2019-09-30 | Novartis Ag | Označevalci povezani z občutljivostjo na inhibitorje humanega dvominutnega 2 proteina (mdm2) |
| WO2014022830A2 (en) | 2012-08-03 | 2014-02-06 | Foundation Medicine, Inc. | Human papilloma virus as predictor of cancer prognosis |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| KR102393608B1 (ko) | 2012-09-04 | 2022-05-03 | 가던트 헬쓰, 인크. | 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법 |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| CA2886605A1 (en) | 2012-09-28 | 2014-04-03 | Cepheid | Two-primer pcr for microrna multiplex assay |
| US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| AU2013326980B2 (en) | 2012-10-04 | 2019-08-15 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US20150291953A1 (en) | 2012-11-02 | 2015-10-15 | Enzymatics Inc. | Methods and kits for nucleic acid sample preparation for sequencing |
| HK1214830A1 (zh) | 2012-11-05 | 2016-08-05 | Foundation Medicine, Inc. | 新型ntrk1融合分子及其应用 |
| EP3561072A1 (en) * | 2012-12-10 | 2019-10-30 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| ES2703764T3 (es) | 2012-12-14 | 2019-03-12 | Chronix Biomedical | Biomarcadores personalizados para el cáncer |
| US11158425B2 (en) | 2013-01-05 | 2021-10-26 | Foundation Medicine, Inc. | System and method for managing genomic information |
| US20140242581A1 (en) | 2013-01-23 | 2014-08-28 | Reproductive Genetics And Technology Solutions, Llc | Compositions and methods for genetic analysis of embryos |
| EP2954054B1 (en) | 2013-02-08 | 2018-12-05 | Qiagen GmbH | Method for separating dna by size |
| EP4253558B1 (en) | 2013-03-15 | 2025-07-02 | The Board of Trustees of the Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| EP3409791B1 (en) * | 2013-03-15 | 2021-06-30 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
| EP4524972A3 (en) | 2013-05-10 | 2025-06-18 | Foundation Medicine, Inc. | Analysis of genetic variants |
| US20150072344A1 (en) | 2013-09-10 | 2015-03-12 | Imdaptive Incorporated | Barcoded Universal Marker Indicator (BUMI) Tags |
| US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
| WO2015073711A1 (en) | 2013-11-13 | 2015-05-21 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
| CN103668471B (zh) * | 2013-12-19 | 2015-09-30 | 上海交通大学 | 一种构建dna高通量测序文库的方法及其配套试剂盒 |
| EP3378952B1 (en) | 2013-12-28 | 2020-02-05 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| EP4039811B1 (en) * | 2014-01-31 | 2023-09-20 | Integrated DNA Technologies, Inc. | Improved methods for processing dna substrates |
| EP3114231B1 (en) | 2014-03-03 | 2019-01-02 | Swift Biosciences, Inc. | Enhanced adaptor ligation |
| US10975371B2 (en) | 2014-04-29 | 2021-04-13 | Illumina, Inc. | Nucleic acid sequence analysis from single cells |
| JP2017522866A (ja) | 2014-06-26 | 2017-08-17 | １０エックス ジェノミクス， インコーポレイテッド | 核酸配列の分析 |
| US10102337B2 (en) | 2014-08-06 | 2018-10-16 | Nugen Technologies, Inc. | Digital measurements from targeted sequencing |
| DK3194612T3 (da) * | 2014-08-22 | 2024-10-14 | Resolution Bioscience Inc | Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| JP2017525369A (ja) * | 2014-09-05 | 2017-09-07 | キアゲン ゲーエムベーハー | アダプター連結アンプリコンの調製 |
| EP3191628B1 (en) * | 2014-09-12 | 2022-05-25 | The Board of Trustees of the Leland Stanford Junior University | Identification and use of circulating nucleic acids |
| EP3192869B1 (en) * | 2014-09-12 | 2019-03-27 | MGI Tech Co., Ltd. | Isolated oligonucleotide and use thereof in nucleic acid sequencing |
| ES2989276T3 (es) | 2014-12-05 | 2024-11-25 | Found Medicine Inc | Análisis multigénico de muestras tumorales |
| WO2016094853A1 (en) | 2014-12-12 | 2016-06-16 | Verinata Health, Inc. | Using cell-free dna fragment size to determine copy number variations |
| ES2923602T3 (es) | 2014-12-31 | 2022-09-28 | Guardant Health Inc | Detección y tratamiento de enfermedades que muestran heterogeneidad celular de enfermedad y sistemas y métodos para comunicar los resultados de las pruebas |
| EP4012715B1 (en) | 2015-02-10 | 2025-09-24 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening and fetal analysis |
| CN108026572B (zh) | 2015-07-23 | 2022-07-01 | 香港中文大学 | 游离dna的片段化模式的分析 |
| US11756655B2 (en) | 2015-10-09 | 2023-09-12 | Guardant Health, Inc. | Population based treatment recommender using cell free DNA |
| EP3359695B1 (en) | 2015-10-10 | 2020-04-15 | Guardant Health, Inc. | Methods and applications of gene fusion detection in cell-free dna analysis |
| EP3889257A1 (en) | 2015-11-11 | 2021-10-06 | Resolution Bioscience, Inc. | High efficiency construction of dna libraries |
| US10095831B2 (en) | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
| KR20220018627A (ko) | 2016-02-29 | 2022-02-15 | 파운데이션 메디신 인코포레이티드 | 종양 돌연변이 부담을 평가하기 위한 방법 및 시스템 |
| WO2017214557A1 (en) | 2016-06-10 | 2017-12-14 | Counsyl, Inc. | Nucleic acid sequencing adapters and uses thereof |
| AU2017315769B2 (en) | 2016-08-25 | 2024-02-01 | Resolution Bioscience, Inc. | Methods for the detection of genomic copy changes in DNA samples |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| EP3792922A1 (en) | 2016-09-30 | 2021-03-17 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| ES2980292T3 (es) * | 2016-11-17 | 2024-09-30 | Lgc Clinical Diagnostics Inc | Métodos para preparar material de referencia y controles de ADN |
| CA3048420C (en) | 2016-12-09 | 2025-05-20 | Boreal Genomics Inc | Linked ligation |
| HUE063675T2 (hu) | 2017-04-14 | 2024-01-28 | Guardant Health Inc | Adapterek minta-nukleinsavakhoz kapcsolására szolgáló eljárások |
| GB2595076B8 (en) | 2018-11-21 | 2023-08-23 | Agilent Technologies Inc | Methods for targeted nucleic acid library formation |
-
2016
- 2016-11-10 EP EP21152311.3A patent/EP3889257A1/en not_active Withdrawn
- 2016-11-10 ES ES16865029T patent/ES2856598T3/es active Active
- 2016-11-10 KR KR1020187016475A patent/KR102788327B1/ko active Active
- 2016-11-10 IL IL285202A patent/IL285202B2/en unknown
- 2016-11-10 CN CN201680076637.6A patent/CN108431233B/zh active Active
- 2016-11-10 RU RU2018121254A patent/RU2018121254A/ru not_active Application Discontinuation
- 2016-11-10 MX MX2018005858A patent/MX2018005858A/es unknown
- 2016-11-10 JP JP2018524250A patent/JP6913089B2/ja active Active
- 2016-11-10 AU AU2016353133A patent/AU2016353133B2/en active Active
- 2016-11-10 CN CN202210236083.9A patent/CN115044645A/zh active Pending
- 2016-11-10 EP EP16865029.9A patent/EP3374525B1/en active Active
- 2016-11-10 WO PCT/US2016/061395 patent/WO2017083562A1/en not_active Ceased
- 2016-11-10 DK DK16865029.9T patent/DK3374525T3/da active
- 2016-11-10 CA CA3004435A patent/CA3004435A1/en active Pending
-
2018
- 2018-04-27 US US15/965,048 patent/US11339391B2/en active Active
- 2018-05-09 MX MX2023008338A patent/MX2023008338A/es unknown
- 2018-05-09 IL IL259237A patent/IL259237B/en unknown
-
2021
- 2021-01-26 JP JP2021010196A patent/JP7223788B2/ja active Active
-
2022
- 2022-01-28 US US17/587,230 patent/US20220267763A1/en active Pending
- 2022-04-21 JP JP2022070030A patent/JP7318054B2/ja active Active
-
2023
- 2023-06-16 JP JP2023099273A patent/JP2023113960A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018121254A (ru) | Высокоэффективное построение библиотек днк | |
| US11352670B2 (en) | Methods of determining tissues and/or cell types giving rise to cell-free DNA, and methods of identifying a disease or disorder using same | |
| JP2019504618A5 (enExample) | ||
| CN108138209B (zh) | 通过原位扩增制备细胞游离核酸分子的方法 | |
| RU2019108294A (ru) | Способы обнаружения изменений количества геномных копий в образцах днк | |
| JP2019526257A5 (enExample) | ||
| CN105793438B (zh) | 未知序列的双股线性核酸的全长扩增方法 | |
| US20220033916A1 (en) | Methods and compositions for early cancer detection | |
| US20230265486A1 (en) | Methods for selective cell-free nucleic acid analysis | |
| EP3990548A1 (en) | Methods and systems for disease detection | |
| WO2022271857A1 (en) | Gene expression and cell-free dna methods and systems for disease detection | |
| CN115151657A (zh) | 用于疾病检测的方法和系统 | |
| WO2021231455A1 (en) | Cell-free dna size detection | |
| CN120500545A (zh) | 肿瘤核酸识别方法 | |
| HK40110787A (en) | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same | |
| WO2024192294A1 (en) | Methods and systems for generating sequencing libraries | |
| WO2022103750A1 (en) | Methods and systems for sample normalization | |
| CN107974486A (zh) | 一种乳腺癌术后复发风险检测方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20191111 |